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Resistance of tumors to ‘‘oncolytic’’ viral
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cellular mRNA translation upon infection.
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Residual cell-intrinsic innate immunity in cancer cells
hampers infection with oncolytic viruses. Transla-
tional control of mRNA is an important feature of
innate immunity, yet the identity of translationally
regulated mRNAs functioning in host defense re-
mains ill-defined. We report the translatomes of
resistant murine ‘‘4T1’’ breast cancer cells infected
with three of the most clinically advanced oncolytic
viruses: herpes simplex virus 1, reovirus, and
vaccinia virus. Common among all three infections
are translationally de-repressed mRNAs, including
Inpp5e, encoding an inositol 5-phosphatase that
modifies lipid second messenger signaling. We find
that viral infection induces the expression of an
Inpp5emRNA variant that lacks repressive upstream
open reading frames (uORFs) within its 50 leader and
is efficiently translated. Furthermore, we show that
INPP5E contributes to antiviral immunity by altering
virus attachment. These findings uncover a role for
translational control through alternative 50 leader
expression and assign an antiviral function to the
ciliopathy gene Inpp5e.
INTRODUCTION
Mammaliancells possess a sophisticatedcell-intrinsic innateanti-
viral program that is activated upon infection. Transcriptional in-
duction of type I interferon expression (IFN-a and -b) and down-
stream interferon-stimulated genes (ISGs) is a major arm of the
innate immune response to infection (Schneider et al., 2014).4010 Cell Reports 29, 4010–4023, December 17, 2019 ª 2019 The A
This is an open access article under the CC BY license (http://creativeAnother essential feature of this response is themRNA translation
arm of innate immunity, a reprogramming of protein synthesis to
permit the expression of cellular antiviral proteins while concur-
rently thwarting theproductionof viral proteins (Walsh et al., 2013).
Translation initiation can be modulated by several eukaryotic
initiation factors (eIFs) and RNA-binding proteins (RBPs) (Sonen-
berg andHinnebusch, 2009). In addition to them7G cap structure,
which helps recruit eIFs, other cis-acting sequence elements that
lie within 50 leaders, such as 50 terminal oligopyrimidine (TOP) mo-
tifs, upstreamopen reading frames (uORFs), internal ribosomeen-
try sites (IRESs), RBP binding sites, or localized secondary struc-
ture can govern the translational efficiency (TE) ofmRNAs (Leppek
et al., 2018; Shi and Barna, 2015). During infection, signaling cas-
cades that feed intomRNA translation such as phosphatidylinosi-
tol 3-kinase (PI3K)/mammalian target of rapamycin complex 1
(mTORC1)/(S6K or 4E-BP) and ERK/MNK/eIF4E were shown to
enhance the translation of antiviral mRNAs, including IRF7 and
ISG15 (Colina et al., 2008; Zakaria et al., 2018). Conversely, trans-
lation initiation can be transiently suppressed following infection
by preventing efficient ribosome assembly through the activation
of eIF2a kinases and subsequent phosphorylation of the a subunit
of eIF2 (P-eIF2a) (Hoang et al., 2018). In contrast, some cellular
mRNAs that have uORFs (e.g., ATF4; Blais et al., 2004) and/or
IRES (e.g., cIAP1/BIRC2; Graber et al., 2010) in their 50 leaders
display enhanced TE in conditions of high P-eIF2a. Alternative
mRNA transcription, splicing, and polyadenylation can also indi-
rectly modify translational output by altering 50 leaders and
30 UTRs, thus changing the composition of sequence elements
that affect TE (Wang et al., 2016).
Viruses use a plethora of strategies to maximize TE of their
own mRNAs, from evolving 50 leaders that are better substrates
for translation due to the presence of IRES to deploying proteins
that shutdown global cellular translation (host shutoff) (Walsh
et al., 2013). Surveying which cellular and viral mRNAs areuthor(s).
commons.org/licenses/by/4.0/).
translated in this highly dynamic environment has been the sub-
ject of some recent studies (Dai et al., 2017; Tirosh et al., 2015).
However, these investigations did not specifically address how
the translation of mRNAs encoding putative pro- or antiviral
effectors could modulate infection. Furthermore, the identifica-
tion of host mRNAs under translational control during infection
could provide targetable strategies to improve antiviral therapies
or alleviate viral resistance, an undesirable feature of tumor cells
in the context of oncolytic virus therapy, which represents a
promising class of cancer therapeutics that relies on natural or
engineered cancer cell tropism and mobilization of adaptive,
anti-tumor immunity (Harrington et al., 2019).
In this work, we ask which mRNA substrates of translation
contribute to the viral resistance of 4T1 breast cancer cells in-
fected with each of three leading oncolytic viruses: herpes sim-
plex virus 1-1716 (HSV1; Sorrento Therapeutics), reovirus type
3 Dearing (also called Reolysin; reovirus; Oncoytics Biotech),
and vaccinia virus JX-594 (VACV; Sillajen). Comparing viral
versus mock infected, we identify translationally upregulated
host mRNAs common to all three infections. We show that the
50 leaders of these mRNAs are enriched in uORFs and are trans-
lationally repressed in mock conditions but become de-
repressed upon infection. This subset includesmRNAs encoding
proteins that are associated with primary cilium homeostasis.
We characterize the important ciliopathy gene Inpp5e, encoding
an inositol 5-phosphatase, and describe a virus-induced mRNA
variant switch that releases its uORF-mediated translation
repression. This response limits viral propagation as cells defi-
cient in INPP5E exhibit increased cell surface attachment of
virions and subsequent infection efficiency. These findings high-
light the dynamic landscape of alternative 50 leader usage during
viral infection and identify INPP5E as a translationally induced
antiviral effector that limits oncolytic virus efficacy.
RESULTS
Transcription and Translation Are Uncoupled in
Response to Oncolytic Virus Infection of 4T1 Cells
To assess translationally regulated innate immune genes, we
used HSV1, reovirus, and VACV individually to infect 4T1 cells,
a murine mammary carcinoma model that is refractory to viral
oncolysis and closely resembles stage IV human breast cancer.
Each of these viruses has a different rate of infection that even-
tually results in the shutdown of host cell translation (Walsh et al.,
2013). We therefore selected an effective dose that is cytopathic
for 50% (ED50) of 4T1 cells at 48 h post-infection (Figure 1A). At
18 h post-infection, polysome profiles (Figure 1B) and 35S-methi-
onine labeling (Figure 1C) showed robust viral protein synthesis,
while that of the host cells was only slightly affected. Themajority
of cells were infected at this dose and time point, confirmed by
co-expression of a virion-derived GFP transgene in the case of
HSV1 and VACV (Figure S1A).
We profiled both the transcriptome and translatome signa-
tures of 4T1 cells, with each individual infection compared to
mock-infected controls using the ribosome-profiling method
(summarized in Figure 1D) (Ingolia et al., 2009). By in-parallel
sequencing of ribosome-protected footprints (RPFs) and total
mRNA (RNA), the ribosome occupancy and thus TE (RPF/RNA)of individual mRNA species was quantitated. In contrast to total
RNA read densities, which were constant throughout the exonic
regions, RPF densities were found to increase within annotated
coding sequences (CDSs) relative to 50 leaders and 30 UTRs,
which is consistent with ribosomes engaged in translation (Fig-
ure S1B). Regression analysis of reads normalized to CDS length
and sequencing depth (reads per kilobase of CDS per million
reads sequenced [RPKM]) in two biological replicates showed
a high degree of correlation at both the RNA (i.e., transcriptome)
and the RPF (i.e., translatome) genomic levels (Figure S1C).
These data demonstrate that ribosome profiling successfully
captured the transcriptional and translational states of the 4T1
genome following challenge with three distinct oncolytic viruses.
We next determined the differentially expressed genes (DEGs)
at the transcriptome and translatome levels in virus- versus
mock-infected 4T1 cells (Table S1). We used a cutoff of 1.5-
fold change in expression up or down and found that reovirus
modified transcript abundance to a higher degree (24% of
sequenced genes) than HSV1 (5.7%) or VACV (1.5%) (Figure 1E,
top). In stark contrast, TEs were perturbedmore consistently be-
tween all three viruses: reovirus (18% of sequenced genes),
VACV (12%), and HSV1 (15%) (Figure 1E, bottom). We also
found a poor correlation between the transcriptome and the
translatome (Pearson’s correlation coefficients of 0.46, 0.20,
and 0.24 for reovirus, VACV, and HSV1 versus mock, respec-
tively) (Figure 1F). Thus, changes in the transcriptional profile of
any given gene is a poor predictor of its TE, a finding that has
been replicated in other experimental contexts (Schwanha¨usser
et al., 2011; Tebaldi et al., 2012).
Genes of the Common Translatome between All Three
Infections Function in Pathways Not Previously
Associated with Viral Infections
A primary objective of this study was to identify innate immunity
effectors that could function in a general antiviral program during
any of the three infections. To this end, we determined the set of
DEGs common to all three infections at both the transcriptome
and the translatome levels (Figure 2A; Table S2). We performed
Gene Ontology (GO) functional enrichment analysis on these
shared sets and found the expected functional groups at the
transcriptional level, including terms encompassing pattern
recognition signaling, response to infection, inflammatory
response, and nucleic acid binding (Figure 2B). Of note, many
previously validated ISGs (Schoggins et al., 2011) were found
to be uniquely upregulated at the level of transcription with
reovirus, VACV, or HSV1 infection, respectively (Figure S2A).
Moreover, these ISGs populated 38% (13/34) of the transcrip-
tionally upregulated DEGs common to all three infections
(Figure S2B).
Functional enrichment at the level of the common translatome
was found to be very different, with few specific GO terms.
Translationally downregulated genes fell into categories encom-
passing catabolic and developmental cellular functions, while
the upregulated common set was found to be enriched in genes
involved in microtubule organization and the primary cilium, an
organelle with a unique cytoskeleton and subcellular proteome
that is often referred to as the cell’s signaling antenna (Boldt
et al., 2016) (Figure 2C; Table S3). Confirming the GO analysis,Cell Reports 29, 4010–4023, December 17, 2019 4011
Figure 1. Transcription and Translation Are Uncoupled in Response to Oncolytic Virus Infection of 4T1 Cells
(A) Infectious dose-response viability curves for the three different viruses used in this study in murine 4T1 breast carcinoma cells.
(B and C) Polysome profiles of virus-infected versus mock-infected 4T1 cells at 18 h post-infection (B) and metabolic labeling with 35S-methionine followed by
SDS-PAGE to resolve nascent peptides (C).
(D) Schematic illustration of the ribosome-profiling strategy used in this study.
(E) Differential expression of sequenced genes (total number shown in top right of plots) at both the transcriptional and the translational genome levels. Each point
on the plots represent the average RNA expression or TE from two biological replicates. Genes that were up- (red) or downregulated (blue) >1.5-fold were
considered to be differentially expressed.
(F) Correlation analysis of RNA-normalized (transcriptome) and RPF-normalized (translatome) abundance between viruses (all relative to mock infected).
Pearson’s correlation coefficients are presented.there was significant enrichment (p = 1.25 3 104) of genes
encoding proteins that constitute the ciliary interactome (Fig-
ure 2D) (Boldt et al., 2016). Thus, using ribosome profiling, the
anticipated transcriptional but unexpected translational signa-
tures of the antiviral state in oncolytic virus-infected 4T1 were
obtained. This suggests that viral infection engenders a distinc-
tive reprogramming of cellular translation.
Oncolytic Viruses De-repress Translation of Host
mRNAs Enriched in uORFs
To characterize the mode of control exerted on the translation-
ally regulated transcripts, we looked for enrichment of RNA-
binding protein motifs and microRNA (miRNA) target sequences
(Figures S3A and S3B). We also surveyed the GC content of
these annotated transcripts as well as the lengths of their 504012 Cell Reports 29, 4010–4023, December 17, 2019leaders, CDSs, and 30 UTRs, comparing them to all NCBI
Reference Sequence (RefSeq) mouse mRNAs. While we found
no significant difference in GC content, the shared translationally
regulated mRNAs (either up- or downregulated) tended to have
shorter 50 leaders, CDSs, and 30 UTRs (Figure 3A). In analyzing
the distribution of TEs for the commonly upregulated set of
genes, we noted that this subset was dramatically repressed in
mock-infected cells compared to the entire sequenced set (Fig-
ure 3B; compare ‘‘mock’’ distributions). This property appeared
to be mainly due to lower RPF expression in the upregulated
genes (Figure S3C, center). Viral infection acted to significantly
de-repress the translation of these genes independently of
changes at the RNA level (Figure 3B, shift in distribution denoted
by arrow, and Figure S3C, right). In contrast, the downregulated
set of genes followed amock-infected TE distribution profile that
Figure 2. Genes of the Common Translatome between All Three Infections Function in Pathways Not Previously Associated with Viral
Infections
(A) Venn diagrams illustrating the common and unique sets of DEGs between viral infections at transcriptional and translational levels.
(B) Network analysis of enriched GO terms for the DEGs commonly regulated by all three oncolytic viruses at the transcriptional level. Generic terms are
concentrated at the center and specific terms lie at the extremities. Node diameter and edge thickness are proportional to the number of genes belonging to or
overlapping with GO terms, respectively.
(C) As in (B), except at the level of the translatome.
(D) Percentage of the human proteome (‘‘proteome’’; 1,319/20,195 proteins) versus the percentage of orthologous genes in the common up and down 4T1
translatomes (OV-infected translatome; 19/112) that overlap with the ciliary interactome (Boldt et al., 2016). A Fisher’s exact test was used to determine statistical
significance. The odds ratio is presented with bars representing a 95% confidence interval and indicating an overrepresentation of ciliary proteins in the
OV-infected translatome.was indistinguishable from the entire set of sequenced genes
that shifted to lower TE upon viral infection (Figure 3B, right, de-
noted by arrow). Furthermore, a similar analysis performed on
the upregulated gene sets uniquely associated with each of the
three viruses showed no clear de-repression profile, suggesting
that this property is a specific and common cellular response to
different viral infections (Figure 3C, top). Downregulated mem-
bers of virus-unique sets behaved similarly to the shared set
with respect to their TE distributions (Figure 3C, bottom).
This repression/de-repression profile has previously been
ascribed to cis-acting mechanisms of translational control
involving uORFs. We used an empirically derived list of uORF-containing mouse and human mRNAs (Lee et al., 2012) and
found an overrepresentation in the commonly upregulated set,
while no enrichment was seen for the downregulated set (Fig-
ure 3D). Thus, three different viruses were found to commonly
affect the translation of transcripts whose 50 leaders are more
likely to contain uORFs, suggesting a universal cellular response
to viruses that target cellular mRNAs harboring uORFs.
INPP5E Is Translationally Induced during the Host
Antiviral Response
We next aimed to validate the increased TE of the primary cilium
genes identified in the network analysis. One of these included theCell Reports 29, 4010–4023, December 17, 2019 4013
Figure 3. Oncolytic Viruses De-repress
Translation of Host mRNAs Enriched in
uORFs
(A) Analysis of RefSeq mRNA sequence charac-
teristics that populate the common translationally
regulated gene sets (red or blue bars) compared to
the entire RefSeq database (white bars, see STAR
Methods for details). Statistical significance was
determined using Kruskal-Wallis with Dunn’s post
hoc testing,
(B) Relative frequency distributions of TE for
common upregulated (left) versus downregulated
(right) genes show that the former are translation-
ally de-repressed (directional shifts indicated by an
arrow). A Mann-Whitney statistical test was used.
(C) Analysis as in (B), but for the translationally
regulated gene sets that are unique to each virus.
(D) Frequency of uORFs in all mouse and human
transcripts in the TiS database (7,361/26,735; http://
tisdb.human.cornell.edu) compared to that present
in the translationally upregulated (52/110) and
downregulated (17/85) sets of transcripts common
toall 3 infections. The increased frequencyof uORFs
in the commonly upregulated set was found to
be significant by Fisher’s exact test, with the odds
ratios presented with bars representing a 95%
confidence interval, indicating overrepresentation of
uORF-containing transcripts in theupregulatedgene
set. **p<0.01, ***p<0.001, ns, non-significant.ciliopathy gene Inpp5e, an inositol 5-phosphatase linked to Jou-
bert syndrome (Nachury et al., 2007). We reasoned that as
Inpp5e TE is induced during virus infection, the double-stranded
RNA (dsRNA) mimic poly(I:C) that induces an antiviral state via
activation of IFN regulatory factor 3 (IRF3) and nuclear factor kB
(NF-kB) should be able to recapitulate this control of INPP5E
expression. While barely detectable in 4T1 cells in control condi-
tions, immunofluorescence (IF) staining of INPP5E notably
increased upon poly(I:C) treatment (Figure 4A, quantified in Fig-
ure 4B), yet Inpp5e mRNA abundance trended lower following
the same treatment (Figure 4C). Consistent with the ribosome-
profiling results, we observed that INPP5E protein measured by
IF in wild-type 4T1 cells (Inpp5e+/+) appeared at low levels in
mock conditions but is robustly induced uponVACV infection (Fig-
ure 4D, quantified in Figure 4E). To confirm the specificity of the IF
signal, we turned to CRISPR/Cas9 technology to generate two
clones of 4T1 cells depleted of INPP5E (Inpp5eCRISPR#1,
Inpp5eCRISPR#2). Tracking of indels by decomposition (TIDE) anal-
ysis (Brinkman et al., 2014) determined that the Inpp5e locus was
modified at a frequency close to 100% with a mixture of three in-4014 Cell Reports 29, 4010–4023, December 17, 2019dels that would be predicted to disrupt
expression (Figures S4A–S4C). The
VACV-mediated induction of INPP5E pro-
tein seen in wild-type cells was lost in In-
pp5eCRISPR#1 cells, despite a robust infec-
tion marked by strong GFP expression
(Figure 4D, quantified in Figure 4E). Again,
consistent with a post-transcriptional ef-
fect, total mRNA levels of Inpp5ewere un-
affectedwith VACV infection at similar MOIand time point (Figure 4F). HSV1 gE protein acts as an Fc receptor
and binds immunoglobulin G (IgG) of various host species (Jo-
hansson et al., 1985), which we used as secondary antibodies
for IF detection. Thus, we could not use IF to determine whether
HSV1 caused a similar induction of INPP5E. We instead used
western blotting andobserved aband (with an apparentmolecular
weight of 62 kDa) inducedwithHSV1 infection in 4T1 cells (Figures
4G and S4D). Similar to the VACV data, we found that the HSV1-
specific signal was lost in Inpp5eCRISPR#1 cells, despite a similar
expression ofHSV1protein ICP0, indicating specificity for INPP5E
(Figure S4D). The induction of INPP5E occurred in another cancer
cell line, the mouse glioblastoma CT2A (Figure 4G). As was the
case for either poly(I:C) or VACV treatments, Inpp5emRNA abun-
dance was not affected by HSV1 infection in either 4T1 or CT2A
cells (Figure 4G).
The above data argue for the post-transcriptional regulation of
Inpp5e in these contexts; however, post-translational changes
such as increased protein stability may explain the increased
expression of INPP5E with infection. We therefore determined
the TE of Inpp5emRNA using conventional polysome profiling, in
Figure 4. INPP5E Is Translationally Induced during the Host Antiviral Response
(A) Representative confocal images of anti-INPP5E stained 4T1 cells treated with poly(I:C) at 5 mg/mL or vehicle for 18 h.
(B) Quantification of the INPP5E IF signal in (A) normalized to mock.
(C) qRT-PCR of Inpp5e normalized to Rps20 mRNA abundance in mock- or poly(I:C)-treated 4T1 cells for 18 h.
(D) As in (A), comparing INPP5E expression in mock-infected Inpp5e+/+ or Inpp5eCRISPR#1 4T1 cells or cells infected with VACV at 5 MOI.
(E) Quantification of the INPP5E IF signal in (D) (normalized to mock-infected cells).
(F) qRT-PCR of Inpp5e mRNA in mock-infected or VACV-infected 4T1 cells at 5 MOI for 24 h.
(G) Top: representative western blots of steady-state INPP5E protein expression inmock-infected andHSV1-infected 4T1 or CT2A cells at 18 h post-infection at 1
MOI. b-Actin is included as a loading control. Apparent molecular weights are indicated to the left in kilodaltons. Bottom: qRT-PCR of Inpp5e normalized toRps20
mRNA abundance in mock-infected or HSV1-infected cells at 24 h post-infection at 5 MOI in 4T1 and CT2A cells.
(H) Left: representative polysome profiles of mock-infected and HSV1-infected CT2A cells 4 h post-infection at MOI of 5. Right: distribution of Inpp5e and Actb
mRNAs across sub-polysomes (low TE) and polysomes (high TE) in mock-infected versus HSV1-infected samples.
Error bars indicate standard error of the mean (sem). *p < 0.05, **p < 0.01, ns, non-significant, calculated using two-tailed t test.
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Figure 5. Expression of an Alternative 50 Leader during Infection Releases Inpp5e from uORF-Mediated Translational Repression
(A) RefSeq-annotated Inpp5e transcripts showing ‘‘long’’ and ‘‘short’’ variants. RefSeq accessions are indicated. Deep sequencing readswere aggregated from a
pool of samples in the Sequencing Read Archive (SRA; NCBIMusmusculus Annotation Release 106) and plotted (right) based on intron-spanning reads from the
short 50 leader intron or the first intron common to both transcripts.
(B) Chromatogram of read densities (reads per million [RPM]) merged from the two biological replicates of ribosome profiling in this study for the Inpp5e locus at
both RNA and RPF gene expression levels showing a shift in RPF reads from the 50 leader to the mORF following infection.
(C) Translation reporter assay in 4T1 cells showing that the long Inpp5e 50 leader strongly represses the translation of the CAT ORF. Constructs used are pictured
to the left and were co-transfected with a b-galactosidase (GAL) reporter to normalize any differences in transfection. The long leader-mediated repression is
substantially weakened with a single mutation that abolishes a uORF start codon (AUG[192]AAG) demonstrating a bona fide uORF mechanism of translational
regulation.
(D) Translation reporter assay as in (C), but in 4T1 cells transfected with in vitro transcribed CAT RNA evaluated at 18 h post-HSV1 infection; n = 2 biological
replicates.
(E) Agarose gel with resolved PCR amplicons from a 4T1 cDNA library indicates the expression of both the short and long Inpp5e 50 leaders in HSV1-infected cells
(a single set of primers flank the 50 leader intron, pictured at right).
(F) qRT-PCR of short versus total Inpp5e mRNA showing an increased expression of the short variant with HSV1 infection after 48 h of infection in either 4T1 or
CT2A cells, and VACV-infected 4T1 at 24 h post-infection or poly(I:C)-treated CT2A for 18 h.
(G) qRT-PCR of Ifnb1 normalized to Rps20 mRNA expression in CT2A cells treated with poly(I:C) for 18 h.
(H) Poly(I:C)-mediated induction of the short Inpp5e variant is PKR independent. Poly(I:C) 8 mg/mLwas transfected into PKR+/+ or PKR/MEFs, and short versus
total Inpp5e RNA levels were determined by qRT-PCR 18 h later. A two-way ANOVA with Sidak post hoc test was used to determine significance.
(legend continued on next page)
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which mRNAs are resolved based on the number of associated
ribosomes. HSV1 infection (MOI of 5) was found to slightly but
consistently reduce global mRNA translation at 4 h post-infection
(Figure 4H, left). Unlike ActbmRNA, the majority (80%) of which
was found in the polysome fraction in uninfected CT2A cells,
Inpp5e residedmainly (60%) in sub-polysomes, which is indica-
tive of a repressed translation state and consistent with the lack of
observableprotein seen inour IFandwesternblottingexperiments
(Figure 4H, right). However, the distribution of Inpp5e in active
polysomes positively shifted from 35.24% ± 6.12% to 59.21% ±
9.53% between mock- versus HSV1-infected cells, while that of
Actb did not change appreciably (76.49% ± 3.2% and 78.47% ±
6.8%, respectively). Thus, these data demonstrate that Inpp5e
mRNAs, which are translationally repressed in basal conditions,
are under positive translational control during viral infection in
cancer cells, despite a general repression of global translation.
Expression of an Alternative 50 Leader during Infection
Releases Inpp5e from uORF-Mediated Translational
Repression
Our data demonstrated that Inpp5e translation is normally
repressed in 4T1 and CT2A cells, as evidenced by its low TE in
mock-infected cells from ribosome profiling, polysome profiling,
and the low steady-state protein expression observed by west-
ern blotting and IF. Furthermore, the same assays showed that
viral infection de-represses Inpp5e translation. We therefore hy-
pothesized that this repression/de-repression shift is due to
uORF-dependent translational control. There are ‘‘long’’ and
‘‘short’’ mouse Inpp5e mRNA variants with long and short 50
leaders, respectively. The short leader results from a down-
stream alternative transcription start site (altTSS) and alternative
splicing, removing an intron that lies entirely within the 50 leader.
Moreover, the short transcript is predicted to encode a C-termi-
nally truncated protein isoform and is supported in the Sequence
Read Archive (SRA) by intron-spanning reads that account for
5% of all Inpp5e transcripts (Figure 5A), as well as a single
RIKEN clone isolated from neonatal kidney tissue.
A previous genome-wide study of initiating ribosomes listed a
putative uORF in both the long and short Inpp5e 50 leaders (Fig-
ure 5B, top schema shows the long and short Inpp5e mRNA
variant with the location of the putative uORF in dark blue) (Lee
et al., 2012). Critically, in uninfected 4T1 cells, RPF read densities
were concentrated in the Inpp5e leader region (Figure 5B, leader
region highlighted in light blue). This density shifted to the main
ORF (mORF) upon HSV1, reovirus, or VACV infections, which
is strongly suggestive of a regulatory uORF.
To determine the presence of a bona fide uORF, we con-
structed a heterologous DNA reporter plasmid consisting of
the long (601 nt) Inpp5e leader inserted in front of an mORF en-(I) Schematic of the Inpp5e 50 leader region in both the long (top) and short (center)
2, which is non-coding (bottom). Putative start codons are indicated, with numb
Locations of potential uORFs are indicated with dark blue rectangles.
(J) CAT reporter assays were performed as in (C) with uORF start codon muta
triangles) in the long Inpp5e 50 leader construct.
(K) Translation reporter assay of DNA-transfected 4T1 cells showing that the sho
than the long 50 leader variant (601 nt).
Error bars indicate standard error of the mean (sem). *p < 0.05, **p < 0.01, ***p <coding chloramphenicol acetyl transferase (CAT) (Graber et al.,
2010). We found that the long Inpp5e leader confers a very
strong repressive effect onto CAT expression, with levels ap-
proaching only 20% of that observed in 4T1 cells transfected
with a leaderless construct (Figure 5C). Mutating the methio-
nine-coding AUG start codon of the putative uORF at 192 nt
(uORF192; present in both long and short leaders) to AAG
rescued CAT expression to 60% of the leaderless construct
(Figure 5C). These data show that Inpp5e leaders harbor a
uORF whose translation represses that of the downstream
cistron. This likely explains why this transcript is normally
repressed at the level of translation, as seen in the ribosome
and polysome profiling experiments.
We next tested whether Inpp5e uses a classical uORF de-
repression mechanism to modulate its translation during viral
infection. In this model, translation of uORF192 would dominate
the mORF in basal conditions, while the inverse would prevail
with viral infection. However, 4T1 cells transfected with in vitro
synthesized, capped, and polyadenylated CAT reporter RNA
showed no changes in Inpp5e leader-dependent translation with
HSV1 infection even at high MOI (Figure 5D). Thus, we were un-
able to demonstrate that the induction of Inpp5e translation during
viral infection uses a classical uORF de-repression mechanism.
An alternative possibility is that infection induces a shift in 50
leader expression, potentially favoring the short variant of
Inpp5e. By virtue of its lower 50 leader complexity, this transcript
could conceivably display increased TE. In support of this idea,
we observed a decrease in the Inpp5e 50 leader:CDS ratio of
RNA read densities during virus infection, suggesting a shift in
expression to the short 50 leader variant (Figure S5A). Using the
mixture of isoforms (MISO) algorithm (Katz et al., 2010), we
also found a more generalized alteration of the splicing land-
scape during infection with each of the three viruses. We
detected 195, 229, and 289 differentially spliced events in
reovirus-infected, VACV-infected, or HSV1-infected versus
mock-infected 4T1 cells, respectively (Figures S5B and S5C).
However, MISO was unable to call differentially spliced events
in the list of shared translationally regulated genes, potentially
due to their low mapping density, as most were found to be rarer
mRNAs (Figure S3C, left).
To monitor the expression of the short and long variants, we
designed PCR primers to flank the intron in the 50 leader and
could readily detect the long variant in either mock- or HSV1-in-
fected 4T1 cells, while the short variant was evident only in the
latter condition (Figure 5E). We next repeated the experiment
in both 4T1 and CT2A cells using qRT-PCR primers designed
to span the exon-exon junction of the short 50 leader and found
that the short variant in uninfected 4T1 or CT2A cells represented
3.32% ± 0.325% and 8.89% ± 1.53%, respectively, of the totalmRNA transcript variants in reading frame 1, which encodes INPP5E, and frame
ering relative to the first A of the Inpp5e AUG start codon in the long variants.
tions (CUG[400]UUG, CUG[391]UUG, AUG[192]AAG; indicated by blue
rt Inpp5e 50 leader variant (348 nt) is a markedly better substrate for translation
0.001, ****p < 0.0001, ns, non-significant, calculated using two-tailed t test.
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Figure 6. INPP5E Acts as an Antiviral Effector That Modifies Viral Binding
(A) Representative fluorescencemicroscopy images of virus infections at MOI of 0.1 for 24 h (VSVD51-RFP) or 48 h (HSV1-GFP and VACV-GFP) in Inpp5eCRISPR#1
versus Inpp5e+/+ 4T1 cells.
(B) Titration of virus obtained from the supernatant of Inpp5eCRISPR#1 versus Inpp5e+/+ 4T1 cells infected with the indicated viruses at 0.01 MOI for 24 h
(VSVD51-RFP) or 48 h (HSV1 and VACV).
(C) Live-cell measurements of HSV1-GFP infection in both Inpp5eCRISPR clones compared to control 4T1. Cells were infected at an MOI of 0.1 and images were
taken every 2 h.
(D) Plaque assay in indicated CRISPR cells. Cells were infected with VSVD51, HSV1, and VACV at an MOI of 0.01, then plaques were enumerated from full-well
fluorescence microscopy images.
(legend continued on next page)
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abundance of Inpp5e mRNA (total Inpp5e was detected with
primers annealing to a 30 exon common to both the long and
short transcripts) (Figure 5F). Infection with HSV1 caused a sig-
nificant increase in the expression of the short variant relative
to total Inpp5e mRNA levels to 10.19% ± 2.8% and 46.08% ±
11.74% in 4T1 and CT2A, respectively (Figure 5F). Similarly,
VACV infection elevated the short:total Inpp5e mRNA ratio
from 4.2% ± 0.00037% to 12.5% ± 0.014% in 4T1 cells (Fig-
ure 5F). Moreover, poly(I:C) treatment was also found to consis-
tently enhance short variant expression in CT2A at 8 h post-treat-
ment (Figure 5F), concomitant with a robust induction Ifnb1
mRNA expression, which is indicative of a typical response to
the dsRNA mimic (Figure 5G). Protein kinase R (PKR) activation
has been previously shown to modulate mRNA splicing (Ilan
et al., 2017); therefore, we asked whether induction of the short
Inpp5e variant was dependent on this kinase. Although we could
recapitulate the poly(I:C)-mediated induction of the short variant
in wild-type mouse embryonic fibroblasts (MEFs), there was a
similar induction in their PKR null counterparts, suggesting that
induction of this short variant is PKR independent (Figure 5H).
We reasoned that there may be other uORFs in the 50 leader
intronic region that repress the translation of the mORF and
are spliced out during viral infection. Two other ribosome-
profiling studies in lipopolysaccharide-treated dendritic cells
(Fields et al., 2015) and SOX-treated keratinocytes (Sendoel
et al., 2017) showed relatively strong initiating ribosome peaks
at two near-cognate CUG start codons at 400 and 391 nt
upstream of the main CDS, respectively (referred to here as
CUG400 and CUG391) (Figure S5D, upper blue track). In addi-
tion, elongating ribosome footprints are abundant in the 50
leader, which is suggestive of active uORF translation (Fig-
ure S5D, lower red track). The putative uORFs starting at
CUG400 and CUG391 are 141 and 132 nt in length, respec-
tively, and in-frame with each other but out-of-frame with the
other uORFs and the mORF (Figure 5I). To determine whether
these codons are used to initiate the translation of bona fide
uORFs, we mutated each of them in the Inpp5e long leader
CAT construct and determined CAT expression. Mutating the
400 or 391 CUG codon to UUG resulted in a significant
enhancement in CAT expression in either construct (Figure 5J).
Thus, near-cognate CUG start codons in the 50 leader intron
contribute to uORF-mediated repression of Inpp5e translation.
Finally, we asked whether the short Inpp5e transcript variant is
a better substrate for translation. Comparison of CAT expression
in transfected 4T1 cells revealed that the short (spliced) 50 leader
confers a 2-fold enhancement of CAT expression relative to the
long (unspliced) 50 leader (Figure 5K). These data expound a
complex expression profile for Inpp5e; repressive uORFs
prevent the inappropriate translation of Inpp5e under normal(E) Top: schematic of the cold-binding assays. Inpp5eCRISPR and Inpp5e+/+ cells
4C for 1 h followed by 37C for 1 h (internalization assay). Total DNAwas extracte
DNA. Bottom: graphs presenting the effect of Inpp5eCRISPR on virus attachme
attachment in each cell type expressed as a ratio (right).
(F) HSV1-K26-GFP cold-binding assay. As in (E), but using a virus decorated w
puncta by confocal microscopy in fixed cells. Images are single confocal slices rep
interference contrast.
Error bars indicate standard error of the mean (sem). *p<0.05, **p<0.01, ***p<0.0conditions but are removed following viral infection to enhance
its translation.
INPP5E Functions as an Antiviral Effector That Modifies
Viral Binding
We next investigated the potential function of INPP5E in modu-
lating viral infection using our Inpp5eCRISPR cells. These cells
exhibited an increased expression of virally expressed GFP
following HSV1 infection relative to wild-type 4T1 cells (Fig-
ure 6A). Infection with VSVD51 (a negative-sense, single-
stranded RNA oncolytic virus candidate) was also enhanced in
Inpp5eCRISPR cells, although no clear difference was observed
with VACV (Figure 6A). In addition, we knocked down Inpp5e
expression in CT2A cells using a short hairpin RNA (shRNA)
and found an increase in HSV1 protein expression relative to
cells expressing non-targeting shRNA (shNTC) (Figure S6A).
To confirm themicroscopy results, we quantified the production
of infectious virus particles in the media of infected Inpp5eCRISPR
4T1 cells. Cells lacking INPP5E exhibited a 2-log increase in
HSV1 viral particle production compared to Inpp5e+/+ 4T1 cells
(Figure 6B). Althoughwe observed consistent increases in fluores-
cencewith VSVD51 bymicroscopy, there was only a small but sig-
nificant increase in viral titer (5-fold increase, p < 0.001) and no
significant change was observed in VACV titers, suggesting that
the INPP5E effect in curtailing infection may be virus specific.
Notably, RNA-mediated reduction in BBS9, another ciliary protein
under translational control in our screen, also rendered 4T1 cells
more permissive to viral infection (Figures S6B and S6C). In
contrast, decreasing the expression of two translationally downre-
gulated genes, Usp18 and Usp44, compromised HSV1 infectivity
(Figures S6D and S6E), suggesting that not only are antiviral genes
translationally upregulated but also potential proviral genes are
downregulated as part of a concerted effort by the host to quash
infection.
To determine the stage(s) of the viral life cycle that could be
affected by Inpp5e, we examined whether Inpp5eCRISPR cells
could support increased viral spread. We infected cells with
HSV1-GFP at low MOI (0.1) and measured GFP intensity and
area every 2 h using a live-cell-imaging system. By quantitating
the area of GFP signal in infected clusters normalized to the total
imaged surface area at multiple time points, a more pronounced
spread in the two Inpp5eCRISPR 4T1 cell lines compared to the
control cell line was observed (Figure 6C). We found that this
INPP5E-mediated effect on viral infection was not specific to
cancer cells; HSV1 or VSVD51 infection also exhibited enhanced
spread following shRNA-mediated knockdown of Inpp5e in the
normal fibroblast cell line NIH 3T3 (Figures S6F and S6G). The
response in NIH 3T3 was more attenuated than that in 4T1
Inpp5eCRISPR cells at 48 h post-infection (compare Figures 6Cwere incubated at 4C with HSV1 at an MOI of 10 for 1 h (attachment assay) or
d and viral UL30DNAwas quantified by qPCR and normalized to cellular Lmnb2
nt (left), internalization (center), and the contribution of internalization versus
ith a GFP-fusion coat protein that allowed the detection of diffraction-limited
resenting the mid-cell region. Nuclei are stained with Hoechst. DIC, differential
01, ns, non-significant, calculated using two-tailed t-test.
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and S6F). However, we cannot rule out the possibility that this
was due to residual INPP5E present in the NIH 3T3 cells. As a
proxy measurement for viral binding and/or entry, we modified
the classical plaque assay by infecting a monolayer of live or
Inpp5e+/+ 4T1 cells in an agar matrix (to prevent cell-to-cell
spread of virion) with HSV1, VSVD51, or VACV at very low MOI
(0.01). Inpp5eCRISPR cells generated >2-fold more plaques
when exposed to HSV1 in contrast to no change in the number
of VACV or VSVD51 plaques (Figure 6D). These data
suggest that viral binding and/or entry of HSV1 is enhanced in
Inpp5eCRISPR cells.
To further investigate the role of INPP5E in early HSV1 infec-
tion, we separately assessed cell attachment or internalization
of virions using two parallel cold-binding assays (Figure 6E,
schema at top) that quantified virus particles via qPCR of
HSV1 genomic DNA (gDNA) copies (Mar et al., 2018). In the
attachment assay, 6.8- and 4.3-fold more viral DNA was
found to be associated with the surface-bound fraction in
Inpp5eCRISPR#1 and Inpp5eCRISPR#2 versus Inpp5e+/+ cells,
respectively (Figure 6E, lower left). A similar trend was measured
with the internalization assay, in which 4.4- and 6.4-fold more
viral DNA was found within Inpp5eCRISPR#1 and Inpp5eCRISPR#2
cells, respectively, relative to control cells (Figure 6E, lower
center). The internalization:attachment ratio did not significantly
change in the Inpp5eCRISPR cells, indicating that the binding of
HSV1 virions to the cell surface is significantly enhanced inde-
pendently of internalization (Figure 6E, lower right). Furthermore,
in a parallel cold-binding experiment using HSV1 expressing a
GFP fusion of the capsid protein VP26, which allows visualization
of virions as diffraction-limited puncta, a sizable increase in the
number of GFP puncta binding to Inpp5eCRISPR cells was
observed (Figure 6F).
These data define translationally regulated antiviral effectors,
with the phosphatidylinositol (PI) phosphatase INPP5E being
further characterized in our study.While INPP5E is translationally
induced by all three of the viruses we assayed, its expression ap-
pears to have a pronounced antiviral effect in the context of
HSV1 infection, modulating viral attachment to and spread
between host cells.
DISCUSSION
To thwart virus infection, mammalian cells suppress the activity
of their mRNA translation machinery, while viruses often attempt
to take control of it to maximize translation of their own mRNAs
(Hoang et al., 2018;Walsh et al., 2013). However, the synthesis of
antiviral proteins is still needed, and single-gene studies have
shown that some of these transcripts are uniquely upregulated
at the translation level, distinct from transcriptionally induced
ISGs (Colina et al., 2008; Herdy et al., 2012). Our present work
reveals a global profile of host cellular mRNAs differentially trans-
lated in a breast cancer cell model infected by clinically relevant
oncolytic viruses.
We find that translationally regulated mRNAs in this context
are functionally enriched in proteins involved in primary cilium
homeostasis. Our sentinel gene, INPP5E, is a target of genetic
mutation in humans, responsible for ciliopathies such as Joubert
syndrome andmental retardation, truncal obesity, retinal dystro-4020 Cell Reports 29, 4010–4023, December 17, 2019phy, and micropenis (MORM) syndrome (Jacoby et al., 2009).
Mainly localized at the primary cilium, it has also been observed
within the nucleus and at centrioles (Sierra Potchanant et al.,
2017). Our IF data in poly(I:C)- or VACV-treated cells shows a
punctate distribution pattern of induced INPP5E that is reminis-
cent of vesicles. This is perhaps unsurprising, given the pre-
sumedmembrane localization of INPP5E, with its C-terminal far-
nesylation and its role in modifying PI signaling (Jacoby et al.,
2009). INPP5E is an inositol 5-polyphosphatase, and therefore
likely controls second messenger PI signaling at vesicular struc-
tures as it does within the cilium, where it maintains a high con-
centration of PI-4-phosphate (PI(4)P) relative to PI(4,5)P2, an
attribute linked to ciliary stability (Dyson et al., 2017; Phua
et al., 2017). Another second messenger, PI(5)P, is induced by
Newcastle disease virus infection and poly(I:C) and can act as
an innate immune effector promoting type I IFN production
through the TANK-binding kinase 1 (TBK1)-IRF3 signaling axis
(Kawasaki et al., 2013). Several viruses activate PI3K signaling
pathways (Walsh et al., 2013); this increases PI(3,4,5)P3 and
consequently activates the Akt-mTOR signaling axis, thus
modulating infection efficiency. PI(4,5)P2 and PI(3,4,5)P3, two
likely INPP5E substrates, are well-known mediators of actin re-
modeling (Saarikangas et al., 2010). We found a positive effect
of INPP5E removal on both HSV1 and VSVD51 infections, and
this may be explained by changes to the actin cytoskeleton
(e.g., changes in membrane ruffling that alter viral attachment)
(Taylor et al., 2011). Consistent with this hypothesis, we
observed enhanced binding of HSV1 to the cell surface, while
internalization remained unaffected. While INPP5E can be local-
ized to the cilium, viral attachment did not appear to be polarized
as one would expect if enhanced binding occurred at or near
ciliary structures. Thus, INPP5E antiviral activities may be not
related to its ciliary localization. Away from the plasma mem-
brane, centrosomal PIs can also be affected by a lack of INPP5E,
leading to spindle microtubule destabilization, possibly through
an imbalance in PI(4,5)P2 expression (Sierra Potchanant et al.,
2017). Whether these mechanisms have a role to play in medi-
ating the enhanced virus binding and infection seen in 4T1 cells
is subject to future investigation.
Another ciliary gene we examined, BBS9, encodes a protein
that serves as a structural component of the BBSome, a stoichio-
metric, octameric protein complex (composed of BBS1, -2, -5, -7,
-8, -9, and -10) charged with receptor cargo destined for the pri-
mary cilium (Nachury et al., 2007); however, others have shown
that theBBSome is important in the transport of extra-ciliary cargo
to the plasma membrane (Starks et al., 2015) and in retrograde
transport (Yen et al., 2006). Mutations in BBS9 and other BBS
genes underlie Bardet-Biedel syndrome, a rare pleiotropic disor-
der that is thought to arise from cilia dysfunction. We have found
that akin to INPP5E, BBS9 expression limits HSV1, VACV, and
VSVD51 infections. Whether impaired BBSome function is
responsible for the proviral effect that we observed with BBS9
knockdown in 4T1 cells will require more investigation. BBS9
might instead display BBSome-independent antiviral functions.
We show here that translationally upregulated mRNAs com-
mon to all three infections were normally repressed at the level
of translation in the uninfected condition. In a search for a mech-
anistic explanation of this repression-de-repression switch, we
noted an enrichment of uORFs in their 50 leaders, a cis-acting
sequence element that can confer translational de-repression
during the accumulation of P-eIF2a (Barbosa et al., 2013).
Further investigation using Inpp5e 50 leader reporter assays re-
vealed no uORF-dependent de-repression during infection.
Instead, a variant switch during infection with HSV1 or VACV or
upon treatment with the viral mimic poly(I:C) was observed, pro-
ducing an alternatively transcribed and spliced transcript with a
shortened Inpp5e 50 leader. Critically, we found that the spliced
50 leader intron harbors repressive uORFs, and consequently,
the short Inpp5e 50 leader is a better substrate for translation
than its longer, unspliced counterpart. We also found enrichment
of bindingmotifs for the splicing factors SRSF1 and SRSF9 in the
50 leader of translationally regulated genes, again, suggestive of
a role for alternative splicing in modifying translation of these
genes. Thus, our study presents evidence for a regulatory mech-
anism in which translational output of an antiviral gene is modu-
lated via a transcript variant shift that increases expression of a
normally minor variant that harbors a less translationally repres-
sive leader.
These findings are in line with previous studies proposing a
role for regulating protein synthesis via transcript variants (Floor
and Doudna, 2016) and follows the axiom that alternative tran-
scription and splicing increases transcriptome diversity from a
more limited and inflexible genome. Clearly, differences in the
coding region between transcript variants can produce function-
ally different protein isoforms, but differences in the non-coding
regions (50 leader and 30 UTR) similarly confer important changes
to protein function by altering protein abundance in time and
space (Floor and Doudna, 2016; Mayr and Bartel, 2009). These
regions contain cis-elements that regulate mRNA turnover, loca-
tion, and/or translation. They can be altered via alternative
transcription, splicing, start-site selection, or alternative polya-
denylation and termination. Examples of differential transcript
variant expression have been reported during infection with
various viruses (Ku et al., 2011; Wang et al., 2018). More specif-
ically, RNA sequencing (RNA-seq) has revealed widespread dis-
turbances to host transcription termination caused by HSV1
infection (Rutkowski et al., 2015) and has identified HSV1
ICP27 protein as a major viral factor responsible for modulating
the host transcript variant landscape (Tang et al., 2016). Aberrant
splicing can lead to defective innate immunity during the host
response to virus infection. For instance, the lack of the RNA-
binding protein BUD13 causes the retention of the 4th intron in
human IRF7 upon stimulation by poly(I:C) or IFN-a, generating
a defective mRNA and impaired antiviral response when chal-
lenged with VSV (Frankiw et al., 2019). In the present study, we
observed the opposite effect from both a mechanistic and a
phenotypic perspective: viral infection or poly(I:C) treatment
caused splicing of an intron and potentiation of the host antiviral
response, rather than intron retention and abrogation of that
response. The question remains: How does infection signal the
switch to an alternative ‘‘ribosome-engaged’’ transcriptome?
PKR-mediated splicing has been previously reported (Ilan
et al., 2017); however, we were unable to link PKR activation to
our change in variant expression. Further studies will be required
to home in on the signaling axis that mediates the increased
expression of the short Inpp5e transcript.In summary, we describe herein a post-transcriptional mech-
anism for the appropriate expression of potent antiviral genes.
Our data suggest that innate immunity projects a complicated
regulatory landscape in which various host and viral factors are
translationally modulated through interactions with pre-mRNA
and splicing complexes. In cataloging the genes that are part
of the translational arm of innate immunity, we have uncovered
regulatory nodes that may benefit from future study with the
goal of improving cancer therapeutics.
STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
d KEY RESOURCES TABLE
d LEAD CONTACT AND MATERIALS AVAILABILITY
d EXPERIMENTAL MODEL AND SUBJECT DETAILSB Cell culture and viruses
d METHOD DETAILS
B Lentivirus production and plasmids
B Poly(I:C) treatment
B Polysome profiling
B Metabolic labeling and cell viability
B Ribosome profiling
B Mapping and analysis of ribosome profiling data
B Functional analysis of DEGs
B Immunocytochemistry
B Western blotting
B Quantitative RT-PCR (RT-qPCR) and Droplet Digital
RT-PCR (RT-ddPCR)
B CAT translation reporter assays
B CRISPR/Cas9-mediated gene knockout
B Live cell monitoring of virus spread
B Plaque assays
B Binding assays
d QUANTIFICATION AND STATISTICAL ANALYSES
d DATA AND CODE AVAILABILITY
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.
celrep.2019.11.072.
ACKNOWLEDGMENTS
We thank Drs. John Bell, Martin Holcik, Antonis Koromilas, Karen Mossman
and David Stojdl for materials used in the experiments. H.-D.H. is a recipient
of a University of Ottawa Graduate Scholarship, an Ontario Graduate Scholar-
ship, and a University of Ottawa Faculty of Medicine Destination 2020 Schol-
arship. This work was supported in part by the Canadian Breast Cancer Foun-
dation/Canadian Cancer Society Research Institute, the Cancer Research
Society/CIHR Institute of Cancer Research (grant 22124), the Natural Sciences
and Engineering Research Council of Canada (RGPIW-2016-05228), and the
Terry Fox Research Institute (New Frontier Program Project Grant, to T.A.
and T.E.G.).
AUTHOR CONTRIBUTIONS
T.A., H.-D.H., T.E.G., and S.M.J. conceived and designed the experiments.
H.-D.H. and T.E.G. performed the majority of the experiments, including theCell Reports 29, 4010–4023, December 17, 2019 4021
functional analysis of the ribosome-profiling data. H.-D.H., T.E.G., and T.A.
wrote themanuscript. J.-J.J. produced the viruses and performed the viral titer
assays. N.V. performed the heterologous reporter assays. V.H.G. performed
the western blotting. X.X. performed qRT-PCR. T.A., C.G.G., and S.M.J. per-
formed the wet component of the ribosome profiling. W.L. performed the ribo-
some-profiling mapping. K.N.C., M.J., and T.A. reviewed and edited the final
manuscript. All of the authors read and approved the final manuscript.
DECLARATION OF INTERESTS
The authors declare no competing interests.
Received: July 2, 2019
Revised: October 16, 2019
Accepted: November 15, 2019
Published: December 17, 2019
REFERENCES
Abernathy, E., Clyde, K., Yeasmin, R., Krug, L.T., Burlingame, A., Coscoy, L.,
and Glaunsinger, B. (2014). Gammaherpesviral gene expression and virion
composition are broadly controlled by accelerated mRNA degradation.
PLoS Pathog. 10, e1003882.
Barbosa, C., Peixeiro, I., and Rom~ao, L. (2013). Gene expression regulation by
upstream open reading frames and human disease. PLoSGenet. 9, e1003529.
Blais, J.D., Filipenko, V., Bi, M., Harding, H.P., Ron, D., Koumenis, C., Wouters,
B.G., and Bell, J.C. (2004). Activating transcription factor 4 is translationally
regulated by hypoxic stress. Mol. Cell. Biol. 24, 7469–7482.
Boldt, K., van Reeuwijk, J., Lu, Q., Koutroumpas, K., Nguyen, T.M., Texier, Y.,
van Beersum, S.E., Horn, N., Willer, J.R., Mans, D.A., et al.; UK10K Rare
Diseases Group (2016). An organelle-specific protein landscape identifies
novel diseases and molecular mechanisms. Nat. Commun. 7, 11491.
Brinkman, E.K., Chen, T., Amendola, M., and van Steensel, B. (2014). Easy
quantitative assessment of genome editing by sequence trace decomposition.
Nucleic Acids Res. 42, e168.
Colina, R., Costa-Mattioli, M., Dowling, R.J.O., Jaramillo, M., Tai, L.-H., Breit-
bach, C.J., Martineau, Y., Larsson, O., Rong, L., Svitkin, Y.V., et al. (2008).
Translational control of the innate immune response through IRF-7. Nature
452, 323–328.
Dai, A., Cao, S., Dhungel, P., Luan, Y., Liu, Y., Xie, Z., and Yang, Z. (2017).
Ribosome Profiling Reveals Translational Upregulation of Cellular Oxidative
Phosphorylation mRNAs during Vaccinia Virus-Induced Host Shutoff.
J. Virol. 91, e01858-e16.
Desai, P., and Person, S. (1998). Incorporation of the green fluorescent protein
into the herpes simplex virus type 1 capsid. J. Virol. 72, 7563–7568.
Diallo, J.-S., Va¨ha¨-Koskela, M., Le Boeuf, F., and Bell, J. (2012). Propagation,
Purification, and In Vivo Testing of Oncolytic Vesicular Stomatitis Virus Strains.
Methods Mol. Biol. 797, 127–140.
Dyson, J.M., Conduit, S.E., Feeney, S.J., Hakim, S., DiTommaso, T., Fulcher,
A.J., Sriratana, A., Ramm, G., Horan, K.A., Gurung, R., et al. (2017). INPP5E
regulates phosphoinositide-dependent cilia transition zone function. J. Cell
Biol. 216, 247–263.
Fields, A.P., Rodriguez, E.H., Jovanovic, M., Stern-Ginossar, N., Haas, B.J.,
Mertins, P., Raychowdhury, R., Hacohen, N., Carr, S.A., Ingolia, N.T., et al.
(2015). A Regression-Based Analysis of Ribosome-Profiling Data Reveals a
Conserved Complexity to Mammalian Translation. Mol. Cell 60, 816–827.
Floor, S.N., and Doudna, J.A. (2016). Tunable protein synthesis by transcript
isoforms in human cells. eLife 5, e10921.
Frankiw, L., Majumdar, D., Burns, C., Vlach, L., Moradian, A., Sweredoski,
M.J., and Baltimore, D. (2019). BUD13 Promotes a Type I Interferon Response
by Countering Intron Retention in Irf7. Mol. Cell 73, 803–814.e6.
Gandin, V., Sikstro¨m, K., Alain, T., Morita, M., McLaughlan, S., Larsson, O.,
and Topisirovic, I. (2014). Polysome fractionation and analysis of mammalian4022 Cell Reports 29, 4010–4023, December 17, 2019translatomes on a genome-wide scale. J. Vis. Exp. (87) https://doi.org/10.
3791/51455.
Gordon, A. (2010). FASTX-Toolkit. FASTQ/A short-reads pre-processing tools.
http://hannonlab.cshl.edu/fastx_toolkit/.
Graber, T.E., Baird, S.D., Kao, P.N., Mathews, M.B., and Holcik, M. (2010).
NF45 functions as an IRES trans-acting factor that is required for translation
of cIAP1 during the unfolded protein response. Cell Death Differ. 17, 719–729.
Harrington, K., Freeman, D.J., Kelly, B., Harper, J., and Soria, J.-C. (2019).
Optimizing oncolytic virotherapy in cancer treatment. Nat. Rev. Drug Discov.
18, 689–706.
Herdy, B., Jaramillo, M., Svitkin, Y.V., Rosenfeld, A.B., Kobayashi, M., Walsh,
D., Alain, T., Sean, P., Robichaud, N., Topisirovic, I., et al. (2012). Translational
control of the activation of transcription factor NF-kB and production of type I
interferon by phosphorylation of the translation factor eIF4E. Nat. Immunol. 13,
543–550.
Hoang, H.-D., Graber, T.E., and Alain, T. (2018). Battling for Ribosomes: Trans-
lational Control at the Forefront of the Antiviral Response. J. Mol. Biol. 430,
1965–1992.
Ilan, L., Osman, F., Namer, L.S., Eliahu, E., Cohen-Chalamish, S., Ben-Asouli,
Y., Banai, Y., and Kaempfer, R. (2017). PKR activation and eIF2a phosphory-
lation mediate human globin mRNA splicing at spliceosome assembly. Cell
Res. 27, 688–704.
Ingolia, N.T., Ghaemmaghami, S., Newman, J.R.S., and Weissman, J.S.
(2009). Genome-wide analysis in vivo of translation with nucleotide resolution
using ribosome profiling. Science 324, 218–223.
Jacoby, M., Cox, J.J., Gayral, S., Hampshire, D.J., Ayub, M., Blockmans, M.,
Pernot, E., Kisseleva, M.V., Compe`re, P., Schiffmann, S.N., et al. (2009). IN-
PP5E mutations cause primary cilium signaling defects, ciliary instability and
ciliopathies in human and mouse. Nat. Genet. 41, 1027–1031.
Jafarnejad, S.M., Chapat, C., Matta-Camacho, E., Gelbart, I.A., Hesketh, G.G.,
Arguello, M., Garzia, A., Kim, S.-H., Attig, J., Shapiro, M., et al. (2018). Trans-
lational control of ERK signaling through miRNA/4EHP-directed silencing.
eLife 7, e35034.
Johansson, P.J., Myhre, E.B., and Blomberg, J. (1985). Specificity of Fc recep-
tors induced by herpes simplex virus type 1: comparison of immunoglobulin G
from different animal species. J. Virol. 56, 489–494.
Katz, Y., Wang, E.T., Airoldi, E.M., and Burge, C.B. (2010). Analysis and design
of RNA sequencing experiments for identifying isoform regulation. Nat.
Methods 7, 1009–1015.
Kawasaki, T., Takemura, N., Standley, D.M., Akira, S., and Kawai, T. (2013).
The second messenger phosphatidylinositol-5-phosphate facilitates antiviral
innate immune signaling. Cell Host Microbe 14, 148–158.
Ku, C.-C., Che, X.-B., Reichelt, M., Rajamani, J., Schaap-Nutt, A., Huang,
K.-J., Sommer, M.H., Chen, Y.-S., Chen, Y.-Y., and Arvin, A.M. (2011). Herpes
simplex virus-1 induces expression of a novel MxA isoform that enhances viral
replication. Immunol. Cell Biol. 89, 173–182.
Langmead, B., and Salzberg, S.L. (2012). Fast gapped-read alignment with
Bowtie 2. Nat. Methods 9, 357–359.
Lee, S., Liu, B., Lee, S., Huang, S.X., Shen, B., and Qian, S.B. (2012). Global
mapping of translation initiation sites in mammalian cells at single-nucleotide
resolution. Proc. Natl. Acad. Sci. USA 109, E2424–E2432.
Leppek, K., Das, R., and Barna, M. (2018). Functional 50 UTRmRNA structures
in eukaryotic translation regulation and how to find them. Nat. Rev. Mol. Cell
Biol. 19, 158–174.
Maere, S., Heymans, K., and Kuiper, M. (2005). BiNGO: a Cytoscape plugin to
assess overrepresentation of gene ontology categories in biological networks.
Bioinformatics 21, 3448–3449.
Mar, K.B., Rinkenberger, N.R., Boys, I.N., Eitson, J.L., McDougal, M.B.,
Richardson, R.B., and Schoggins, J.W. (2018). LY6E mediates an evolution-
arily conserved enhancement of virus infection by targeting a late entry step.
Nat. Commun. 9, 3603.
Mayr, C., and Bartel, D.P. (2009). Widespread shortening of 30UTRs by alterna-
tive cleavage and polyadenylation activates oncogenes in cancer cells. Cell
138, 673–684.
Nachury, M.V., Loktev, A.V., Zhang, Q., Westlake, C.J., Pera¨nen, J., Merdes,
A., Slusarski, D.C., Scheller, R.H., Bazan, J.F., Sheffield, V.C., and Jackson,
P.K. (2007). A core complex of BBS proteins cooperates with the GTPase
Rab8 to promote ciliary membrane biogenesis. Cell 129, 1201–1213.
Oliveros, J.C. (2007). VENNY. An interactive tool for comparing lists with Venn
Diagrams. https://bioinfogp.cnb.csic.es/tools/venny/index.html.
Phua, S.C., Chiba, S., Suzuki, M., Su, E., Roberson, E.C., Pusapati, G.V., Se-
tou,M., Rohatgi, R., Reiter, J.F., Ikegami, K., and Inoue, T. (2017). Dynamic Re-
modeling of Membrane Composition Drives Cell Cycle through Primary Cilia
Excision. Cell 168, 264–279.e15.
Riley, A., Jordan, L.E., and Holcik, M. (2010). Distinct 50 UTRs regulate XIAP
expression under normal growth conditions and during cellular stress. Nucleic
Acids Res. 38, 4665–4674.
Rutkowski, A.J., Erhard, F., L’Hernault, A., Bonfert, T., Schilhabel, M., Crump,
C., Rosenstiel, P., Efstathiou, S., Zimmer, R., Friedel, C.C., and Do¨lken, L.
(2015). Widespread disruption of host transcription termination in HSV-1 infec-
tion. Nat. Commun. 6, 7126.
Saarikangas, J., Zhao, H., and Lappalainen, P. (2010). Regulation of the actin
cytoskeleton-plasmamembrane interplay by phosphoinositides. Physiol. Rev.
90, 259–289.
Sanjana, N.E., Shalem, O., and Zhang, F. (2014). Improved vectors and
genome-wide libraries for CRISPR screening. Nat. Methods 11, 783–784.
Schneider, W.M., Chevillotte, M.D., and Rice, C.M. (2014). Interferon-stimu-
lated genes: a complex web of host defenses. Annu. Rev. Immunol. 32,
513–545.
Schoggins, J.W., Wilson, S.J., Panis, M., Murphy, M.Y., Jones, C.T., Bieniasz,
P., and Rice, C.M. (2011). A diverse range of gene products are effectors of the
type I interferon antiviral response. Nature 472, 481–485.
Schwanha¨usser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J.,
Chen, W., and Selbach, M. (2011). Global quantification of mammalian gene
expression control. Nature 473, 337–342.
Sendoel, A., Dunn, J.G., Rodriguez, E.H., Naik, S., Gomez, N.C., Hurwitz, B.,
Levorse, J., Dill, B.D., Schramek, D., Molina, H., et al. (2017). Translation
from unconventional 50 start sites drives tumour initiation. Nature 541,
494–499.
Shannon, P., Markiel, A., Ozier, O., Baliga, N.S., Wang, J.T., Ramage, D., Amin,
N., Schwikowski, B., and Ideker, T. (2003). Cytoscape: a software environment
for integrated models of biomolecular interaction networks. Genome Res. 13,
2498–2504.
Shi, Z., and Barna, M. (2015). Translating the genome in time and space:
specialized ribosomes, RNA regulons, and RNA-binding proteins. Annu.
Rev. Cell Dev. Biol. 31, 31–54.Sierra Potchanant, E.A., Cerabona, D., Sater, Z.A., He, Y., Sun, Z., Gehlhau-
sen, J., and Nalepa, G. (2017). INPP5E Preserves Genomic Stability through
Regulation of Mitosis. Mol. Cell. Biol. 37, e00500-16.
Sonenberg, N., and Hinnebusch, A.G. (2009). Regulation of translation initia-
tion in eukaryotes: mechanisms and biological targets. Cell 136, 731–745.
Starks, R.D., Beyer, A.M., Guo, D.F., Boland, L., Zhang, Q., Sheffield, V.C., and
Rahmouni, K. (2015). Regulation of Insulin Receptor Trafficking by Bardet Biedl
Syndrome Proteins. PLoS Genet. 11, e1005311.
Stojdl, D.F., Lichty, B.D., TenOever, B.R., Paterson, J.M., Power, A.T.,
Knowles, S., Marius, R., Reynard, J., Poliquin, L., Atkins, H., et al. (2003).
VSV strains with defects in their ability to shutdown innate immunity are potent
systemic anti-cancer agents. Cancer Cell 4, 263–275.
Tang, S., Patel, A., and Krause, P.R. (2016). Herpes simplex virus ICP27 reg-
ulates alternative pre-mRNA polyadenylation and splicing in a sequence-
dependent manner. Proc. Natl. Acad. Sci. USA 113, 12256–12261.
Taylor, M.P., Koyuncu, O.O., and Enquist, L.W. (2011). Subversion of the actin
cytoskeleton during viral infection. Nat. Rev. Microbiol. 9, 427–439.
Tebaldi, T., Re, A., Viero, G., Pegoretti, I., Passerini, A., Blanzieri, E., and Quat-
trone, A. (2012). Widespread uncoupling between transcriptome and transla-
tome variations after a stimulus in mammalian cells. BMC Genomics 13, 220.
Tirosh, O., Cohen, Y., Shitrit, A., Shani, O., Le-Trilling, V.T.K., Trilling, M., Fried-
lander, G., Tanenbaum, M., and Stern-Ginossar, N. (2015). The Transcription
and Translation Landscapes during Human Cytomegalovirus Infection Reveal
Novel Host-Pathogen Interactions. PLoS Pathog. 11, e1005288.
Walsh, D., Mathews, M.B., and Mohr, I. (2013). Tinkering with translation: pro-
tein synthesis in virus-infected cells. Cold Spring Harb. Perspect. Biol. 5,
a012351.
Wang, X., Hou, J., Quedenau, C., and Chen,W. (2016). Pervasive isoform-spe-
cific translational regulation via alternative transcription start sites inmammals.
Mol. Syst. Biol. 12, 875.
Wang, P.-H., Fung, S.-Y., Gao, W.-W., Deng, J.-J., Cheng, Y., Chaudhary, V.,
Yuen, K.-S., Ho, T.-H., Chan, C.-P., Zhang, Y., et al. (2018). A novel transcript
isoform of STING that sequesters cGAMP and dominantly inhibits innate nu-
cleic acid sensing. Nucleic Acids Res. 46, 4054–4071.
Yen, H.-J., Tayeh, M.K., Mullins, R.F., Stone, E.M., Sheffield, V.C., and Slusar-
ski, D.C. (2006). Bardet-Biedl syndrome genes are important in retrograde
intracellular trafficking and Kupffer’s vesicle cilia function. Hum. Mol. Genet.
15, 667–677.
Zakaria, C., Sean, P., Hoang, H.-D., Leroux, L.-P., Watson, M., Workenhe,
S.T., Hearnden, J., Pearl, D., Truong, V.T., Robichaud, N., et al. (2018).
Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells
via dysregulated eIF4E/4E-BP axis. PLoS Pathog. 14, e1007264.Cell Reports 29, 4010–4023, December 17, 2019 4023
STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Mouse anti-INPP5E Abcam ab69696, RRID:AB_2126254
Rabbit anti-INPP5E Cohesion Biosciences CPA3073
Mouse anti- b-actin Sigma A5441, AB_476744
Mouse anti-GAPDH Abcam Ab8245, RRID:AB_2107448
Rabbit anti-HSV1 Dako B011402
Mouse anti-HSV1 ICP0 Santa Cruz 11060, RRID:AB_673704
Bacterial and Virus Strains
HSV1 (HSV1716, strain 17 – g34.5 deleted) Sorrento Therapeutic, San Diego, US N/A
VACV (Jennerex-594, strain Wyeth,
Tk-deleted expressing GM-CSF)
Sillagen, Seoul, Republic of Korea N/A
Reovirus (Reolysin, Type 3 Dearing) Oncolytics Biotech, Calgary, Canada N/A
VSVD51-RFP (DM51 with insertion of RFP
marker
Stojdl et al., 2003 N/A
HSV1-K26-GFP (HSV1 with insertion of
GFP to vp26)






Chemicals, Peptides, and Recombinant Proteins
High Molecular Weight poly(I:C) InvivoGen tlrl-pic
Lipofectamine 2000 Fisher 11668019
EasyTagTM Express Protein Labeling Mix Perkin Elmer NEG772002MC
Critical Commercial Assays
Cell Proliferation Kit I – MTT Roche 11465007001
CAT ELISA Roche 11363727001
Deposited Data
Ribosome footprint of infected cancer cells This study GEO: GSE137757
RNaseq of transcriptome of infected cancer
cells
This study GEO: GSE137757
Experimental Models: Cell Lines
4T1 ATCC CRL-2539, RRID:CVCL_0125
HEK293T ATCC CRL-3216, CVCL_0063
CT-2A Laboratory of D. Stojdl N/A
PKR-null/WT MEFs Laboratory of A. Koromilas N/A
NIH 3T3 ATCC CRL-1658, CVCL_0594
Oligonucleotides
See Table S4 N/A N/A
Recombinant DNA
shNTC plasmid DNA (MISSION
pLKO.1-puro Non-Mammalian
shRNA Control Plasmid DNA)
Sigma SHC002
shINPP5E plasmid DNA (MISSION shRNA
plasmid DNA)
Sigma TRCN0000080705
(Continued on next page)
e1 Cell Reports 29, 4010–4023.e1–e5, December 17, 2019
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
shBBS9 plasmid DNA (MISSION shRNA
plasmid DNA)
Sigma TRCN0000182387
shUSP18 plasmid DNA (MISSION shRNA
plasmid DNA)
Sigma TRCN0000030789




FASTX Laboratory of G. Hannon http://hannonlab.cshl.edu/fastx_toolkit/
Bowtie2 Langmead and Salzberg, 2012 http://bowtie-bio.sourceforge.net/
bowtie2/index.shtml
Venny v2.1 Oliveros, 2007 https://bioinfogp.cnb.csic.es/tools/
venny_old/venny.php
BiNGO Maere et al., 2005 http://apps.cytoscape.org/apps/bingo
Cytoscape 3.0 Shannon et al., 2003 https://www.cytoscape.orgLEAD CONTACT AND MATERIALS AVAILABILITY
Further information and request for resources and reagents should be directed to andwill be fulfilled by the Lead Contact, Dr. Tommy
Alain (tommy@mgcheo3.med.uottawa.ca). Material will be made available upon reasonable request.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell culture and viruses
Mouse breast carcinoma 4T1, fibroblast NIH 3T3, human HEK293T and monkey Vero cells were obtained from American Type
Culture Collection (ATCC). Mouse glioblastoma CT2A was obtained from Dr. David Stojdl (Children’s Hospital of Eastern Ontario
Research Institute). PKR null and respective wild-type MEFs were obtained from Dr. Antonis Koromilas (Lady Davis Institute). Cells
were routinely checked formycoplasma contamination by cytoplasmic DNA staining. NIH 3T3, HEK293T, Vero, CT2A andMEFswere
cultured in Dulbecco’s Modified Eagle Medium (DMEM) (Fisher) supplemented with 10% fetal bovine serum (Sigma) and 0.1%
penicillin and streptomycin (Life Technologies) at 37C in 5% CO2. 4T1 were cultured in Roswell Park Memorial Institute (RPMI)
1640 (Fisher) supplemented with 10% fetal bovine serum (Wisent Bioproducts) and 0.1% penicillin and streptomycin. HSV1
(HSV1-1716, strain 17 – g34.5 deleted, Sorrento Therapeutics, San Diego, USA), VACV (JX-594 strain Wyeth, Tk-deleted expressing
GM-CSF, Jennerex Biotherapeutics / Sillagen, Seoul, Republic of Korea) and Reovirus (Reolysin, Type 3 Dearing, – Oncolytics
Biotech, Calgary, Canada) were kindly provided bymanufacturers. VSVD51-RFP (DM51with insertion of RFPmarker) was kindly pro-
vided by Dr. John Bell (Ottawa Hospital Research Institute). HSV1-K26-GFP was kindly provided by Dr. Karen Mossman (McMaster
University). For propagation of HSV1-1716 and HSV1-K26-GFP, monolayer of Vero cells was inoculated with viruses at a MOI of 0.5
and cultured for 72 hours at 37C, 5% CO2. Supernatant was clarified by centrifuge at 500 x g for 5 min, then filtered (0.45 mm). Virus
particles in the supernatant were separated from cellular debris by ultracentrifugation at 17500 x g for 90 min over a sucrose cushion
(36% sucrose, 10 mM HEPES, 150 mM NaCl, 0.1 mM EDTA, pH 7.3). Pellets were resuspended in 1X HNE buffer (10 mM HEPES,
150 mM NaCl, 0.1 mM EDTA, pH 7.3) and stored at 80C. VSVD51 propagation was adapted from a previously described method
(Diallo et al., 2012). Briefly, monolayer of Vero cells was inoculated with VSVD51 at MOI of 0.01. Approximately 24 hours post inoc-
ulation, supernatant was collected and clarified by centrifugation at 500 x g for 5 min. Cleared supernatant are filtered (0.2 mm), then
virus particles were pelleted by ultracentrifugation at 28,000 x g for 90 min. Virus particles in the pellet were resuspended in DMEM
media and stored at 80C. JX-594 and Reovirus were used directly from stock provided by manufacturer.
METHOD DETAILS
Lentivirus production and plasmids
The following lentiviral vectors were obtained from Sigma Aldrich: SHC002 (shNTC); TRCN0000080705 (shINPP5E);
TRCN0000182387 (shBBS9), TRCN0000030789 (shUSP18), TRCN0000030879 (shUSP44). The lentiviral vectors were co-trans-
fected with the packaging plasmids pLP1, pLP2 and pLP/VSVG (Thermofisher) into HEK293T cells. Lentivirus-containing superna-
tants were collected at 48 and 72 hours post-transfection and filtered (0.45 mm). The filtrate was applied directly to target cells and
integration of the expression cassette was confirmed 72 hours post-transduction by puromycin selection at 2 mg/ml for 4 days. The
long mouse Inpp5e 50 leader (nt 1-601) was PCR-amplified from a full-length MGC cDNA clone (GenBank: BC052717; cloneID
6837339 from Dharmacon). This clone is missing the first 31 nucleotides of the annotated long Inpp5e mRNA transcriptCell Reports 29, 4010–4023.e1–e5, December 17, 2019 e2
(NM_033134). The 601 nt 50 leader was cloned into the NotI restriction site of pMC (a kind gift of Dr. Martin Holcik, Carleton University)
upstream of the CAT reporter maintaining the same reading frame as the endogenouse Inpp5e transcript. The short Inpp5e leader
(found in NM_001290437; nt 1-348) was created from the long-leader CAT construct by a deletion overlap extension cloning strategy.
Site-directedmutagenesis was performed tomutate uORF start codons in the long-leader CAT construct. All constructs were verified
by Sanger sequencing.
Poly(I:C) treatment
Cells was transfecting with high molecular weight poly(I:C) (InvivoGen) using Lipofectamine 2000 (Thermo Fisher) according to the
manufacturer protocol at a ratio of 1:2 mg:ml poly(I:C):lipofectamine. A poly(I:C) concentration of 5 mg/ml was used unless otherwise
indicated. For ‘‘vehicle’’ treatments, cells were transfected with lipofectamine 2000 but without poly(I:C).
Polysome profiling
Polysome profiling was conducted as previously described (Gandin et al., 2014). Briefly, cycloheximide (Bioshop, CAT #66-81-9)
was added directly to the culture media to a final concentration of 100 mg/ml and incubated for 5 min. Cells were then washed 3
times with ice cold PBS containing cycloheximide, then were scraped from the dishes and pelleted at 500 x g for 5 min at 4C. Cells
were lysed with hypotonic buffer (5 mM Tris pH 7.5, 2.5 mM MgCl2, 1.5 mM KCl) supplemented with cOmplete Protease Inhibitor
Cocktail (Roche) and debris was cleared by centrifugation at 14,000 x g for 5 min, 4C. Lysates containing ribosome-bound
mRNAs were collected, flash frozen, then stored at 80C. A volume of lysate equal to 10 OD260 units was added on a
10%–50% sucrose gradient and centrifuged at 36,000 rpm in a SW41 bucket rotor for 90 min at 4C. Fractions were collected
using a Brandel Fraction Collector System. RNA was extracted from each fraction using Trizol reagent according to the manufac-
turer’s protocol.
Metabolic labeling and cell viability
Cells were incubated with complete growth media supplementing with EasyTagTM Express Protein Labeling Mix containing both
[35S]-L-methionine and [35S]-L-cysteine (PerkinElmer) at 10 mCi/ml for 30 min at 37C, 5% CO2. Cells were then lysed in radioimmu-
noprecipitation assay (RIPA) buffer (150 mM NaCl, 1.0% IGEPAL-CA-630, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris,
pH 8.0). Proteins were then separated on SDS-PAGE and transferred to a nitrocellulose membrane, followed by exposure to auto-
radiography films. Cell viability wasmeasured 48 hours post-infection using the Cell Proliferation Kit I – MTT (Roche) according to the
manufacturer’s manual.
Ribosome profiling
Ribosome profiling was performed as previously described on 2 biological replicates (Jafarnejad et al., 2018). Briefly, polysomes in
4T1 lysates were stabilized with cycloheximide and 4T1 lysates were split into two parallel workflows. RNA-Seq on total RNA from
one half of the lysate (see below) while RNase I footprinting was performed on the remaining half to capture RPFs. For RNA-Seq,
150 mg of total RNA was taken for RNA-Seq analysis and Poly-(A)+ mRNA was purified using magnetic oligo-dT DynaBeads
(Thermofisher) according to the manufacturer’s instructions. Purified RNA was eluted and mixed with an equal volume of 2X alkaline
fragmentation solution (2 mM EDTA, 10 mM Na2CO3, 90 mM NaHCO3) and incubated for 20 min at 95
C. Fragmentation reactions
were mixed with stop/precipitation solution (300 mM NaOAc pH 5.5 and GlycoBlue), followed by isopropanol precipitation by
standard methods. Fragmented mRNA samples were size-selected on a denaturing 10% urea-polyacrylamide gel. The area corre-
sponding to 35-50 nucleotides was excised, eluted and precipitated with isopropanol. Isolated RPF RNA (corresponding to 28-32 nt
fragments) and total RNA fragments were used to create cDNA libraries as previously described (Jafarnejad et al., 2018). Ribosomal
RNA (rRNA) contamination was reduced by subtractive hybridization using biotinylated oligos that were reverse complements of
abundant rRNAs. The mRNA and ribosome-footprint libraries were then amplified by PCR (10 cycles) using indexed primers and
sequenced on the Illumina HiSeq 2000 platform with read length of 50 nucleotides at the McGill University and Ge´nome Que´bec
Innovation Centre.
Mapping and analysis of ribosome profiling data
The adaptor sequence was removed from reads using FASTX (Gordon, 2010) and reads that mapped to rDNA sequence by Bowtie 2
(Langmead and Salzberg, 2012) were discarded. Reads were then mapped to the mouse genome (mm9) using Bowtie 2. Uniquely
mapped reads with MAPQ scoreR 10 were used for further analysis. For gene expression analysis, reads mapping to the coding
region of RefSeq transcripts were used to calculate Reads Per Kilobase per Million total uniquely mapped reads (RPKM). Gene-level
RPKMs were obtained by conflating and averaging transcript RPKMs. Genes that showed no expression (0 RPKM) at either the
transcription or translation levels in either the mock or infected samples were omitted from further analysis. Translation efficiency
was defined by the log2 ratio of RPF to total RNA RPKMs. For metagene analysis of read distribution around start and stop codons,
reads mapped to RefSeq transcripts were used. For a given region, only genes with at least 128 reads whose 50 end was within the
region were used. The 50 end position of a read was used for the plotting. Subsets of differentially-expressed genes that are common
and unique between the three oncolytic viruses were compiled using Venny v2.1 (Oliveros, 2007).e3 Cell Reports 29, 4010–4023.e1–e5, December 17, 2019
Functional analysis of DEGs
Differentially-expressed genes that were commonly up- or downregulated in all three virus infections were tested for enrichment
(q < 0.10) in Gene Ontology (GO) terms using BiNGO (GO terms downloaded October, 2015) (Maere et al., 2005). GO networks
were plotted with the Enrichment Map plugin within Cytoscape 3.0 (Shannon et al., 2003). The ‘‘R’’ software package in the RStudio
environment or GraphPad Prism was used for all other data manipulation and plotting. For sequence and RNA binding protein
analyses, 50 leaders and 30 UTRs annotated in RefSeq were retrieved from UCSC Tables.
Immunocytochemistry
4T1 cells were cultured as indicated on a 10 mm, #1.5 glass coverslip (Electron Microscopy Science). For intracellular staining, cells
were washed with ice cold PBS followed by fixation in 4% paraformaldehyde in PHEM buffer (60 mM PIPES, 25 mM HEPES, pH6.9,
10 mM EGTA, 2 mMMgSO4) for 10 min at room temperature. Fixed cells were treated with 50 mMNH4Cl in PBS to reduce autofluor-
escence, followed by permeabilization with 0.1% Triton X-100 in PBS for 10 min. Following 3 washes with PBS, the coverslip was
then blocked with 5% BSA in PBS, for 30 min. Permeabilized cells were then incubated with the indicated primary antibody in
1% BSA/PBS overnight. Coverslips were washed 3 times for 5 min each with PBS and incubated with 1:10,000 dilution Goat
anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody Alexa Fluor 568 secondary antibody (#A-11036, Invitrogen) for
1 hour at room temperature in the dark. Coverslips were washed 33 5min with PBS and nuclei were stained with 1:200 of NucBlue
Live Ready Probe-variant of Hoechst dye (Life Technologies) in PBS for 5 min. Coverslips were then mounted onto slides using
Prolong Diamond mounting medium (Life Technologies). Confocal imaging was performed using a FV-1000 confocal microscope
(Olympus) with a PlanApo N 100X/1.40 oil immersion objective lens (Olympus). Non-confocal fluorescence imaging was performed
using an EVOS FL Cell Imaging system (Thermofisher). The following primary antibodies and corresponding dilution are used: 1:100
a-INPP5E (# ab69696, Abcam).
Western blotting
Cells were washed with PBS and lysed in RIPA buffer supplemented with 10 mM NaF, 10 mM Na2VO3 and cOmplete Protease
Inhibitor Cocktail (Roche). Cell debris was removed by centrifugation at 10,000 x g, 10 min, 4C. Protein concentration of the
supernatant was quantified using DC Protein assay (BioRad). Indicated amount of total protein was then loaded onto 10%SDS-poly-
acrylamide gel and separated by electrophoresis. Separated proteins were transferred to a nitrocellulose or PVDF membrane, then
blocked with 5% skimmilk in TBS-T buffer (10 mM Tris, 50 mMNaCl, 0.1% Tween-20, pH 7.5). The following primary antibodies and
corresponding dilution were used: 1:500 a-INPP5E (#CPA3073, Cohesion Biosciences), 1:10,000 a-b-actin (#A5441, Sigma), 1:5000
a-GAPDH (#ab8245, Abcam), 1:2000 a-pan-HSV1 (#B011402, Dako), 1:2000 a-HSV1-ICP0 (#11060, Santa Cruz).
Quantitative RT-PCR (RT-qPCR) and Droplet Digital RT-PCR (RT-ddPCR)
cDNA was reverse transcribed from total RNA using iScript Advanced cDNA Synthesis Kit (BioRad) according to the manufacturer’s
protocol. RT-qPCRwas performed on cDNAmixedwith iQ SyBRGreenmix (BioRad) according to themanufacturer’s protocol, using
a Realplex 2 thermocycler (Eppendorf). The PCR conditions were 95C for 3 min, followed by 40 cycles of 95C for 10 s, 60C for 30 s
and 72C for 30 s. Ct threshold was determined by Realplex software (Eppendorf). For calculating mRNA abundance, the DDCt
method relative to Rps20 expression was used. For calculating short Inpp5e variant ratio, the DDCt method relative to total Inpp5e
expression was used. For the binding assays, RT-qPCR was performed directly on the extracted DNA using the same mix and PCR
conditions as in qPCR assays, then the number of HSV1 genome relative to the number of host genome was calculated using the
DDCt method comparing relative abundance between HSV1UL30 and mouse Lmnb2 abundance. For RT-ddPCR, cDNA was mixed
with QX200 ddPCR EvaGreen Supermix (Biorad) according to the manufacturer’s protocol and droplets were prepared using QX200
droplet generation oil on a QX200 Droplet Generator (Biorad). Droplets were subjected to PCR using a C1000 thermocycler (BioRad)
using the cycling conditions: 95C for 5min, followed by 45 cycles of 95C for 30 s at a ramp rate of 2C/s and 60C for 1min at a ramp
rate of 2C/s. Positive/negative droplets were counted by a QX200 Droplet Reader (BioRad). Primers (listed 50 to 30) used for qPCR
and ddPCR are listed in Table S4. For the gel-based assessment of 50 leader expression, PCR was performed on 4T1 cDNA libraries
using INPP5Eutr-F: CAGTCGTTGTTCCAGCTGC and INPP5E-shortUTR-R: TGAAAACTCGAGTGGCTCCC. For normalization of the
CAT RNA reporter assay (see below), CAT cDNA was amplified using the above-noted ddPCR conditions with previously published
primers (Riley et al., 2010). Melting curves and agarose electrophoresis were performed to control for PCR specificity in all of the
above assays.
CAT translation reporter assays
TheCAT assay has been described previously (Graber et al., 2010). Briefly, 4T1, CT2A orMEFswere seeded at 3 or 6x105 cells/well in
6-well plates, then co-transfected with 1 mg each of b-Galactosidase- (pBGal, obtained from Dr. Martin Holcik) and CAT-expressing
plasmids using Lipofectamine 2000. 24 hours post-transfection, cells were lysed, and CAT expression was quantified using the CAT
ELISA (Roche) as per the manufacturer’s instructions. b-Galactosidase activity was measured using an ortho-Nitrophenyl-b-galac-
toside (ONPG) colorimetric assay. In the case of RNA transfection experiments, a T7-flanked long Inpp5e 50 leader was amplified from
1 ng of the appropriate CAT reporter plasmid. This amplicon was used as a template for synthesis of capped and poly(A)-tailed RNACell Reports 29, 4010–4023.e1–e5, December 17, 2019 e4
using the T7 HiScribe in vitro transcription kit (New England Biolabs) according to the manufacturer’s protocol. 1 mg of RNA was
transfected with 2 mL of Lipofectamine 2000, and at 4 hours HSV1 was added into the media at indicated MOIs and incubated for
an additional 18 hours. Cells were lysed in 300 mL of CAT lysis buffer, and 30 mL was used to isolate total RNA and prepare cDNA
using iScript RT (BioRad). CAT cDNA was amplified by ddPCR using the above-noted primers and conditions. CAT expression
was determined as above and normalized to the CAT RNA levels.
CRISPR/Cas9-mediated gene knockout
CRISPR/Cas9 knockout of INPP5E in 4T1 was performed as previously described (Sanjana et al., 2014). Briefly, small guide RNAs
(sgRNA) targeting the Inpp5e first exon or non-targeting sgRNA (primer sequences in Table S4) were cloned into the lenti-
sgRNA(MS2)-zeomycin backbone (Addgene #61427) using BsmBI. To produce separate Cas9- and sgRNA-expressing lentiviruses,
doxycycline-inducible and puromycin expressing pCW-Cas9 (Addgene #50661) or the constitutively expressing sgRNA vector were
co-transfected with pLP1, pLP2 and pLP/VSVG (Thermofisher) into HEK293T cells using Lipofectamine 2000 (Invitrogen) according
to the manufacturer’s protocol. Cells were then transduced with the lentiviral supernatants and double-transductants were selected
using puromycin and zeomycin. Cas9 expression was then induced using 1 mg/ml doxycycline for 24 hours. Single-cell clones were
obtained by limiting dilution, screened using T7 Endonuclease I (New England Biolabs), and confirmed by Sanger sequencing.
CRISPR/Cas9 modification efficiency was quantitated using TIDE, which deduces the frequency of individual insertion-deletion
(indel) from Sanger sequencing of a mixed population.
Live cell monitoring of virus spread
Live cells monitoring of virus infection was performed using the IncuCyte Live-Cell Analysis system (Sartorius). Cells were seeded in a
24-well plated at 80% confluency, then infected with viruses at the indicated MOI. Multiple phase contrast and fluorescence images
were taken per well every 2 hours. Images were then analyzed using the IncuCyte Zoom software (Sartorius) for GFP cluster inte-
grated intensity (Green calibrated unit x mm2) as a measurement for virus infection. GFP cluster integrated intensity was calculated
using the following customized process definition in Incucyte ZOOM software: background subtraction using Top-Hat method
(disk shape structuring element with radius of 10 mm, threshold of 1.0 green calibrated unit), edge split: Off, Hole Fill: No, Adjust
Size: No, Filters: No.
Plaque assays
For titration, Vero cells were cultured to a monolayer. Cells were then incubated with a serial dilution in DMEM of virus-containing
supernatant for 1 hours, 37C, 5% CO2 with shaking every 10 min. Cells were then washed 3 times with DMEM, then a layer of
DMEM + 10% FBS +1% agar was added on top and allowed to solidify. Cells were then cultured at 37C, 5% CO2 for 48 hours
(VSVD51) or 72 hours (HSV1, VACV). Full-well fluorescence images were taken, and fluorescent plaques were counted and used
for back calculating original viral titer. For modified plaque assay to compare viral entry and spread (Figure 6D), monolayers of
4T1 WT or 4T1 Inpp5eCRISPR were cultured, then incubated virus diluted in RPMI media at a MOI of 0.01. Cells were then washed
3 times with RPMI media, then a layer of RPMI + 10% FBS +1% agar was added on top and allowed to solidify. Cell culture, and
plaque detection and counting were carried out as described above for standard plaque assays.
Binding assays
The cold binding assay was adapted for HSV1 from a previously described method (Abernathy et al., 2014). Briefly, cells were pre-
incubated at 4C for 30 min, then incubated with HSV1-1716 at the indicated MOI at 4C for 1 hour. For internalization, cells were
incubated for 1 hour at 37C, washed with PBS pH 3.0 to remove surface bound viruses. gDNA was harvested using the QIAamp
DNA Mini Kit (QIAGEN) according to manufacturer’s protocol. PCR was performed using primers described above on the DNA.
QUANTIFICATION AND STATISTICAL ANALYSES
All experiments were performed with at least 3 biological replicates unless otherwise specified in figure legends. Statistical
significance was a priori set to 0.05. Two-tailed Student’s t test or one-way ANOVA with Dunett’s post hoc tests were performed
where applicable unless otherwise indicated in the figure legend. Error bars indicate standard error of the mean (sem). *p < 0.05,
**p < 0.01, ***p < 0.001, ****p < 0.0001, ns, non-significant.
DATA AND CODE AVAILABILITY
Raw sequence files have been deposited on the NCBI Gene Expression Omnibus (GEO: GSE137757).e5 Cell Reports 29, 4010–4023.e1–e5, December 17, 2019
